Regulation of apoptosis by PML and the PML-NBs

被引:121
作者
Bernardi, R. [1 ,2 ]
Papa, A. [1 ,2 ]
Pandolfi, P. P. [1 ,2 ]
机构
[1] Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Dept Pathol & Med, Boston, MA 02115 USA
[2] Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Canc Genet Program, Boston, MA 02115 USA
关键词
apoptosis; PML nuclear bodies; tumor suppression; cancer; APL;
D O I
10.1038/onc.2008.305
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The promyelocytic leukemia protein (PML) is a tumor suppressor identified in acute PML and implicated in the pathogenesis of a variety of tumors. PML is essential for the proper assembly of a nuclear macromolecular structure called the PML nuclear body (PML-NB). PML and PML-NBs are functionally promiscuous and have been associated with the regulation of several cellular functions. Above all these is the control of apoptosis, a function of PML whose physiological relevance is emphasized by in vivo studies that demonstrate that mice and cells lacking Pml are resistant to a vast variety of apoptotic stimuli. The function of PML in regulating apoptosis is not confined to a linear pathway; rather, PML works within a regulatory network that finely tunes various apoptotic pathways, depending on the cellular context and the apoptotic stimulus. Here, we will summarize earlier and recent advances on the molecular mechanisms by which PML regulates apoptosis and the implication of these findings for cancer pathogenesis.
引用
收藏
页码:6299 / 6312
页数:14
相关论文
共 104 条
[1]   PML enhances the regulation of p53 by CK1 in response to DNA damage [J].
Alsheich-Bartok, O. ;
Haupt, S. ;
Alkalay-Snir, I. ;
Saito, S. ;
Appella, E. ;
Haupt, Y. .
ONCOGENE, 2008, 27 (26) :3653-3661
[2]   A cytoplasmic PML mutant inhibits p53 function [J].
Bellodi, Cristian ;
Kindle, Karin ;
Bernassola, Francesca ;
Cossarizza, Andrea ;
Dinsdale, David ;
Melino, Gerry ;
Heery, David ;
Salomoni, Paolo .
CELL CYCLE, 2006, 5 (22) :2688-2692
[3]   PML regulates p53 stability by sequestering Mdm2 to the nucleolus [J].
Bernardi, R ;
Scaglioni, PP ;
Bergmann, S ;
Horn, HF ;
Vousden, KH ;
Pandolfi, PP .
NATURE CELL BIOLOGY, 2004, 6 (07) :665-672
[4]   Role of PML and the PML-nuclear body in the control of programmed cell death [J].
Bernardi, R ;
Pandolfi, PP .
ONCOGENE, 2003, 22 (56) :9048-9057
[5]   Structure, dynamics and functions of promyelocytic leukaemia nuclear bodies [J].
Bernardi, Rosa ;
Pandolfi, Pier Paolo .
NATURE REVIEWS MOLECULAR CELL BIOLOGY, 2007, 8 (12) :1006-1016
[6]   SUMO-1 protease-1 regulates gene transcription through PML [J].
Best, JL ;
Ganiatsas, S ;
Agarwal, S ;
Changou, A ;
Salomoni, P ;
Shirihai, O ;
Meluh, PB ;
Pandolfi, PP ;
Zon, LI .
MOLECULAR CELL, 2002, 10 (04) :843-855
[7]   Deconstructing PML-induced premature senescence [J].
Bischof, O ;
Kirsh, O ;
Pearson, M ;
Itahana, K ;
Pelicci, PG ;
Dejean, A .
EMBO JOURNAL, 2002, 21 (13) :3358-3369
[8]   p21-induced cycle arrest in G1 protects cells from apoptosis induced by UV-irradiation or RNA polymerase II blockage [J].
Bissonnette, N ;
Hunting, DJ .
ONCOGENE, 1998, 16 (26) :3461-3469
[9]   Promyelocytic leukemia (PML) nuclear bodies are protein structures that do not accumulate RNA [J].
Boisvert, FM ;
Hendzel, MJ ;
Bazett-Jones, DP .
JOURNAL OF CELL BIOLOGY, 2000, 148 (02) :283-292
[10]   Pondering the promyelocytic leukemia protein (PML) puzzle: Possible functions for PML nuclear bodies [J].
Borden, KLB .
MOLECULAR AND CELLULAR BIOLOGY, 2002, 22 (15) :5259-5269